Why the study?
Are plasma levels of activated protein C (APC) elevated in patients with previous venous thromboembolism and hyperhomocysteinemia compared to healthy controls?
Population
128 patients with previous venous thromboembolism and 98 age- and sex-matched healthy controls. No known…
Design
Case-control
Authors
Loading...
APC elevation may mark in vivo hemostatic activation in hyperhomocysteinemic VTE; leaves open biomarker utility for risk stratification.
Are plasma levels of activated protein C (APC) elevated in patients with previous venous thromboembolism and hyperhomocysteinemia compared to healthy controls?
APC plasma levels are sensitive markers of in vivo hemostatic system activation, and homocysteine does not appear to interfere with protein C activation in vivo.
Cattaneo et al. (1998) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: